Live Events
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
3
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
4
Urocross shows sustained benefit through 24 months post-removal
5